Medovex Corp. (NASDAQ:MDVX) Director Scott Haufe sold 70,000 shares of the firm’s stock in a transaction dated Tuesday, September 19th. The shares were sold at an average price of $1.19, for a total transaction of $83,300.00. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Medovex Corp. (NASDAQ:MDVX) opened at 1.1599 on Friday. Medovex Corp. has a 1-year low of $1.00 and a 1-year high of $1.82. The firm’s 50-day moving average is $1.20 and its 200 day moving average is $1.20. The firm’s market cap is $24.27 million.

TRADEMARK VIOLATION NOTICE: This news story was originally published by Daily Political and is the sole property of of Daily Political. If you are reading this news story on another site, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be accessed at

About Medovex Corp.

MedoveX Corporation, through its subsidiaries, focuses on developing medical devices primarily in the United States and Europe. It offers DenerveX device, a disposable single-use kit for the treatment of various medical applications, including pain relief. The company serves healthcare providers, physicians, and third-party payors.

Insider Buying and Selling by Quarter for Medovex Corp. (NASDAQ:MDVX)

Receive News & Ratings for Medovex Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medovex Corp. and related companies with's FREE daily email newsletter.